Contraceptives in chronic lymphocytic leukemia (CLL): a narrative review

Key Points

• Contraceptive use may impact treatment approaches in chronic lymphocytic leukemia.
• Health risks associated with hormonal therapy in female patients with CLL are notable and require careful consideration.
• Narrative review provides insights into existing literature on contraceptives and oncological risk.
• Highlighting the need for tailored contraceptive counseling in women diagnosed with CLL.